BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
(NASDAQ:BLLN), MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for third quarter ended September 30, 2025 after the market close on […]